{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:25:07Z","timestamp":1793391907854,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Insight into cellular immune responses to COVID-19 vaccinations is crucial for optimizing booster programs in kidney transplant recipients (KTRs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>In an immunologic substudy of a multicenter randomized controlled trial (NCT05030974) investigating different repeated vaccination strategies in KTR who showed poor serological responses after 2 or 3 doses of an messenger RNA (mRNA)-based vaccine, we compared SARS-CoV-2-specific interleukin-21 memory T-cell and B-cell responses by enzyme-linked immunosorbent spot (ELISpot) assays and serum IgG antibody levels. Patients were randomized to receive: a single dose of mRNA-1273 (100 \u03bcg, n\u2005=\u200525), a double dose of mRNA-1273 (2\u2009\u00d7\u2009100 \u03bcg, n\u2005=\u200525), or a single dose of adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2.S) (n\u2005=\u200525). In parallel, we also examined responses in 50 KTR receiving 100 \u03bcg mRNA-1273, randomized to continue (n\u2005=\u200525) or discontinue (n\u2005=\u200525) mycophenolate mofetil\/mycophenolic acid. As a reference, the data were compared with KTR who received 2 primary mRNA-1273 vaccinations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Repeated vaccination increased the seroconversion rate from 21% to 66% in all patients, which was strongly associated with enhanced levels of SARS-CoV-2-specific interleukin-21 memory T cells (odd ratio, 3.84 [1.89-7.78]; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001) and B cells (odd ratio, 35.93 [6.94-186.04]; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001). There were no significant differences observed in these responses among various vaccination strategies. In contrast to KTR vaccinated with 2 primary vaccinations, the number of antigen-specific memory B cells demonstrated potential for classifying seroconversion after repeated vaccination (area under the curve, 0.64; 95% confidence interval, 0.37-0.90; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.26 and area under the curve, 0.95; confidence interval, 0.87-0.97; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.0001, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our study emphasizes the importance of virus-specific memory T- and B-cell responses for comprehensive understanding of COVID-19 vaccine efficacy among KTR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005119","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T04:04:44Z","timestamp":1718942684000},"page":"2420-2433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled Trial"],"prefix":"10.1097","volume":"108","author":[{"given":"S. Reshwan K.","family":"Malahe","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Nephrology and Transplantation, Erasmus MC Transplant Institute, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"den Hartog","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology and Transplantation, Erasmus MC Transplant Institute, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim J. R.","family":"Rietdijk","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"van Baarle","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infection Prevention, Virology and Immunology Research Group, University Medical Center Groningen, Groningen, the Netherlands."},{"name":"Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronella","family":"de Kuiper","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology and Transplantation, Erasmus MC Transplant Institute, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Reijerkerk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology and Transplantation, Erasmus MC Transplant Institute, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia M.","family":"Ras","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology and Transplantation, Erasmus MC Transplant Institute, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Geers","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri A.","family":"Diavatopoulos","sequence":"additional","affiliation":[{"name":"Radboud Institute for Molecular Life Sciences, Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands."},{"name":"Radboud Center for Infectious Diseases, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Lianne","family":"Messchendorp","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate G.","family":"van der Molen","sequence":"additional","affiliation":[{"name":"Radboud Institute for Molecular Life Sciences, Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Imhof","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie C.","family":"Fr\u00f6lke","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands."},{"name":"Renal Transplant Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike J.","family":"Bemelman","sequence":"additional","affiliation":[{"name":"Renal Transplant Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T.","family":"Gansevoort","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk B.","family":"Hilbrands","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Stephan F.","family":"Sanders","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine H.","family":"GeurtsvanKessel","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia M. L.","family":"Kho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology and Transplantation, Erasmus MC Transplant Institute, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory D.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies E. J.","family":"Reinders","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology and Transplantation, Erasmus MC Transplant Institute, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla C.","family":"Baan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology and Transplantation, Erasmus MC Transplant Institute, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of RECOVAC Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/TP.0000000000003983","article-title":"The RECOVAC Immune-response Study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.","volume":"106","author":"Sanders","year":"2022","journal-title":"Transplantation"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.ackd.2018.10.002","article-title":"Vaccination in chronic kidney disease.","volume":"26","author":"Reddy","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3390\/jcm11092565","article-title":"Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients.","volume":"11","author":"Osmanodja","year":"2022","journal-title":"J Clin Med"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients.","volume":"385","author":"Hall","year":"2021","journal-title":"N Engl J Med"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"eabj6513","DOI":"10.1126\/sciimmunol.abj6513","article-title":"Implications of defective immune responses in SARS-CoV-2 vaccinated organ transplant recipients.","volume":"6","author":"Heeger","year":"2021","journal-title":"Sci Immunol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1473-3099(22)00650-8","article-title":"Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.","volume":"23","author":"Kho","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jamainternmed.2021.7372","article-title":"Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients: a randomized clinical trial.","volume":"182","author":"Reindl-Schwaighofer","year":"2022","journal-title":"JAMA Intern Med"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ajt.2023.05.025","article-title":"The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipients.","volume":"23","author":"Malahe","year":"2023","journal-title":"Am J Transplant"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1093\/cid\/ciac571","article-title":"Clinical characteristics and outcomes of immunocompromised patients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational study.","volume":"76","author":"Malahe","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1097\/TP.0000000000004104","article-title":"Effectiveness of COVID-19 vaccines against hospitalization and death with the SARS-CoV-2 delta variant in solid organ and islet transplant recipients.","volume":"106","author":"Williams","year":"2022","journal-title":"Transplantation"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/ajt.17095","article-title":"Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: a population-based cohort study from Canada.","volume":"22","author":"Naylor","year":"2022","journal-title":"Am J Transplant"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"e13788","DOI":"10.1111\/tid.13788","article-title":"Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.","volume":"24","author":"Aslam","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1097\/TP.0000000000003908","article-title":"Two doses of SARS-CoV-2 vaccines reduce risk of death due to COVID-19 in solid organ transplant recipients: preliminary outcomes from a UK registry linkage analysis.","volume":"105","author":"Ravanan","year":"2021","journal-title":"Transplantation"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"eadh4529","DOI":"10.1126\/scitranslmed.adh4529","article-title":"T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.","volume":"15","author":"Zonozi","year":"2023","journal-title":"Sci Transl Med"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","article-title":"Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration.","volume":"179","author":"Kuchen","year":"2007","journal-title":"J Immunol"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","article-title":"IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.","volume":"175","author":"Ettinger","year":"2005","journal-title":"J Immunol"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2567.2007.02730.x","article-title":"Interleukin-21 activates human natural killer cells and modulates their surface receptor expression.","volume":"123","author":"Skak","year":"2008","journal-title":"Immunology"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.it.2016.06.001","article-title":"IL-21 and T cell differentiation: consider the context.","volume":"37","author":"Tian","year":"2016","journal-title":"Trends Immunol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/rai2.12000","article-title":"IL-21 regulates macrophage activation in human monocytic THP-1-derived macrophages.","volume":"1","author":"Jian","year":"2021","journal-title":"Rheumatol & Autoimmun"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/infdis\/jiaa479","article-title":"SARS-CoV-2-specific antibody detection for seroepidemiology: a multiplex analysis approach accounting for accurate seroprevalence.","volume":"222","author":"den Hartog","year":"2020","journal-title":"J Infect Dis"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/cid\/ciab172","article-title":"Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study.","volume":"73","author":"den Hartog","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"e1387","DOI":"10.1097\/TXD.0000000000001387","article-title":"SARS-CoV-2 spike-specific IFN-\u03b3 T-cell response after COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.","volume":"8","author":"Imhof","year":"2022","journal-title":"Transplant Direct"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"101642","DOI":"10.1016\/j.eclinm.2022.101642","article-title":"Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients.","volume":"53","author":"Thomson","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R24-20250604","first-page":"100371","article-title":"SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: a prospective cohort study.","volume":"16","author":"Dib","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.3390\/v14122646","article-title":"Immune response to third and fourth COVID-19 vaccination in hemodialysis patients and kidney transplant recipients.","volume":"14","author":"Affeldt","year":"2022","journal-title":"Viruses"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s44298-024-00015-7","article-title":"Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients.","volume":"2","author":"den Hartog","year":"2024","journal-title":"NPJ Viruses"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cei.12576","article-title":"Follicular T helper cells and humoral reactivity in kidney transplant patients.","volume":"180","author":"de Graav","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"e169793","DOI":"10.1172\/jci.insight.169793","article-title":"IL-21\u2013producing effector Tfh cells promote B cell alloimmunity in lymph nodes and kidney allografts.","volume":"8","author":"Zhang","year":"2023","journal-title":"JCI Insight"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41584-023-00992-8","article-title":"Effect of DMARDs on the immunogenicity of vaccines.","volume":"19","author":"van Sleen","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/ar3835","article-title":"Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus.","volume":"14","author":"Eickenberg","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"e226822","DOI":"10.1001\/jamanetworkopen.2022.6822","article-title":"Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: a systematic review and meta-analysis.","volume":"5","author":"Manothummetha","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"100178","DOI":"10.1016\/j.lanepe.2021.100178","article-title":"Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.","volume":"9","author":"Stumpf","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/ajt.16851","article-title":"Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.","volume":"22","author":"Kantauskaite","year":"2022","journal-title":"Am J Transplant"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"928542","DOI":"10.3389\/fmed.2022.928542","article-title":"MMF\/MPA is the main mediator of a delayed humoral response with reduced antibody decline in kidney transplant recipients after SARS-CoV-2 mRNA vaccination.","volume":"9","author":"Stumpf","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ki.2010.269","article-title":"Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses.","volume":"78","author":"Struijk","year":"2010","journal-title":"Kidney Int"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action.","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"e157836","DOI":"10.1172\/jci.insight.157836","article-title":"Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients.","volume":"7","author":"Schrezenmeier","year":"2022","journal-title":"JCI Insight"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/TP.0000000000004516","article-title":"Immune response to COVID-19 mRNA vaccination in previous nonresponder kidney transplant recipients after short-term withdrawal of mycophenolic acid 1 and 3 months after an additional vaccine dose.","volume":"107","author":"K\u00fchn","year":"2023","journal-title":"Transplantation"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1093\/cid\/ciac557","article-title":"Antibody and T-cell responses 6 months after coronavirus disease 2019 messenger RNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.","volume":"76","author":"Sanders","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection.","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2.","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12874-016-0281-5","article-title":"Outcome-sensitive multiple imputation: a simulation study.","volume":"17","author":"Kontopantelis","year":"2017","journal-title":"BMC Med Res Methodol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:00:34Z","timestamp":1749060034000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005119","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}